Cullinan Oncology Inc.

NASDAQ: CGEM · Real-Time Price · USD
7.95
0.29 (3.79%)
At close: Aug 18, 2025, 2:54 PM

Cullinan Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-167.57M -153.16M 109.19M -67.48M
Depreciation & Amortization
306K 310K 93K 53K
Stock-Based Compensation
37.82M 30.44M 27.96M 24.38M
Other Working Capital
423K -172K 11.69M 1.29M
Other Non-Cash Items
-15.47M -11.52M -275.08M 67K
Deferred Income Tax
n/a n/a n/a 3.1M
Change in Working Capital
-389K -339K 11.18M -3.54M
Operating Cash Flow
-145.3M -134.28M -126.66M -43.43M
Capital Expenditures
n/a -208K -1.13M -589.23K
Cash Acquisitions
n/a -36.01K 275M 923K
Purchase of Investments
-721.13M -373.38M -377.92M -525.81M
Sales Maturities Of Investments
584.82M 409.4M 352.93M 192.04M
Other Investing Acitivies
n/a 36.01K 91K -333.77K
Investing Cash Flow
-136.31M 35.81M 248.97M -333.77M
Debt Repayment
n/a 1.82M -2.2M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
3.54M 538K -32.13M 1.52M
Financial Cash Flow
266.19M 40.75M -25.93M 268.78M
Net Cash Flow
-15.43M -57.72M 96.38M -108.42M
Free Cash Flow
-145.3M -134.48M -127.8M -44.02M